Cargando…
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018
BACKGROUND: People with cystic fibrosis are at increased risk of pulmonary nontuberculous mycobacteria (NTM) disease. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are associated with reduced lung infection with pathogens like Pseudomonas aeruginosa and Staphylococcus aureus....
Autores principales: | Ricotta, Emily E., Prevots, D. Rebecca, Olivier, Kenneth N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995538/ https://www.ncbi.nlm.nih.gov/pubmed/35415188 http://dx.doi.org/10.1183/23120541.00724-2021 |
Ejemplares similares
-
HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
por: Olivier, Kenneth N., et al.
Publicado: (2022) -
Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida
por: Foote, Sydney L., et al.
Publicado: (2021) -
Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016) -
Epidemiology of Nontuberculous Mycobacterial Lung Disease among Cystic Fibrosis Patients Residing in Hawaii, USA
por: Adjemian, Jennifer, et al.
Publicado: (2017) -
Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)
por: Marshall, Julia E., et al.
Publicado: (2023)